IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Pharmaceutical Business of Peak International Products B.V. on November 5, 2020. In 2019, Pharmaceutical Business reported total revenues of approximately €5.8 million. Pharmaceutical Business will be integrated into IMCD Business Group Pharmaceuticals. IMCD N.V. (ENXTAM:IMCD) completed the acquisition of Pharmaceutical Business of Peak International Products B.V. on January 7, 2021.